California Public Employees Retirement System Regenxbio Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$32.46 - $40.48 $2.05 Million - $2.56 Million	-63,250 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$33.61 - $49.95 $206,701 - $307,192	-6,150 Reduced 8.86%	63,250 $2.16 Million
Q4 2020 Feb 02, 2021	SELL	$26.52 - $49.35 $39,780 - $74,025	-1,500 Reduced 2.12%	69,400 $3.15 Million
Q3 2020 Nov 05, 2020	BUY	$27.01 - $40.26 $54,020 - $80,520	2,000 Added 2.9%	70,900 $1.95 Million
Q2 2020 Aug 12, 2020	BUY	$27.75 - $43.44 $24,975 - $39,096	900 Added 1.32%	68,900 $2.54 Million
Q1 2020 May 12, 2020	SELL	$21.5 - $54.2 $83,850 - $211,380	-3,900 Reduced 5.42%	68,000 $2.2 Million
Q4 2019 Jan 27, 2020	BUY	$34.54 - $44.87 $297,044 - $385,882	8,600 Added 13.59%	71,900 $2.95 Million
Q3 2019 Oct 31, 2019	BUY	$31.84 - $50.88 $1.32 Million - $2.11 Million	41,543 Added 190.94%	63,300 $2.25 Million
Q2 2019 Aug 15, 2019	SELL	$42.0 - $59.29 $276,612 - $390,483	-6,586 Reduced 23.24%	21,757 $1.12 Million
Q1 2019 May 03, 2019	SELL	$40.82 - $62.45 $8,164 - $12,490	-200 Reduced 0.7%	28,343 $1.62 Million
Q4 2018 Feb 08, 2019	SELL	$39.11 - $75.15 $46,932 - $90,180	-1,200 Reduced 4.03%	28,543 $1.2 Million
Q3 2018 Nov 13, 2018	BUY	$65.0 - $82.15 $624,260 - $788,968	9,604 Added 47.69%	29,743 $2.25 Million
Q2 2018 Aug 15, 2018	BUY	$27.2 - $74.35 $547,780 - $1.5 Million	20,139 New	20,139 $1.45 Million

Others Institutions Holding RGNX

# of Institutions

193

Shares Held

43.2M

Call Options Held

104K

Put Options Held

478K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $339M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account